Total Payments
$1,958
2024 Payments
$1,907
Companies
2
Transactions
4
Medicare Patients
1,796
Medicare Billing
$97,398

Payment Breakdown by Category

Consulting$1,815 (92.7%)
Food & Beverage$142.90 (7.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $1,815 1 92.7%
Food and Beverage $142.90 3 7.3%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $1,882 3 $0 (2024)
GlaxoSmithKline, LLC. $76.07 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,907 3 AstraZeneca Pharmaceuticals LP ($1,831)
2022 $50.56 1 AstraZeneca Pharmaceuticals LP ($50.56)

All Payment Transactions

4 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
04/26/2024 GlaxoSmithKline, LLC. JEMPERLI (Biological) Food and Beverage In-kind items and services $76.07 General
Category: ONCOLOGY
03/25/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $16.27 General
02/14/2024 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $1,815.00 General
03/21/2022 AstraZeneca Pharmaceuticals LP ENHERTU (Biological) Food and Beverage In-kind items and services $50.56 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 465 788 $240,748 $25,847
2022 13 600 933 $271,147 $29,980
2021 11 413 635 $190,529 $23,673
2020 9 318 462 $129,870 $17,897
Total Patients
1,796
Total Services
2,818
Medicare Billing
$97,398
Procedure Codes
45

All Medicare Procedures & Services

45 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
88173 Evaluation of fine needle aspirate with interpretation and report Facility 2023 56 105 $43,725 $5,566 12.7%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2023 73 139 $34,977 $3,922 11.2%
88341 Special stained specimen slides to examine tissue, each additional procedure Facility 2023 31 129 $16,038 $2,760 17.2%
88112 Cell examination of specimen, selective cellular enhancement technique Facility 2023 103 111 $34,479 $2,298 6.7%
88321 Surgical pathology consultation and report on referred slides prepared elsewhere Facility 2023 36 36 $19,207 $2,290 11.9%
88172 Evaluation of fine needle aspirate Facility 2023 47 75 $31,075 $2,015 6.5%
88331 Pathology examination of specimen during surgery, first tissue block Facility 2023 23 39 $13,446 $1,830 13.6%
88307 Pathology examination of tissue using a microscope, moderately high complexity Facility 2023 12 29 $13,201 $1,805 13.7%
88360 Microscopic genetic analysis of tumor, manual Facility 2023 20 37 $15,576 $1,170 7.5%
88342 Special stained specimen slides to examine tissue, initial procedure Facility 2023 33 39 $11,624 $1,029 8.9%
88177 Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode Facility 2023 17 32 $3,428 $656.65 19.2%
88162 Screening examination of specimen cells, extended study Facility 2023 14 17 $3,972 $505.61 12.7%
88173 Evaluation of fine needle aspirate with interpretation and report Facility 2022 63 104 $41,495 $5,649 13.6%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2022 92 161 $38,775 $4,671 12.0%
88341 Special stained specimen slides to examine tissue, each additional procedure Facility 2022 45 171 $20,328 $3,716 18.3%
88321 Surgical pathology consultation and report on referred slides prepared elsewhere Facility 2022 56 57 $28,848 $3,572 12.4%
88112 Cell examination of specimen, selective cellular enhancement technique Facility 2022 124 141 $41,711 $2,791 6.7%
88172 Evaluation of fine needle aspirate Facility 2022 64 87 $34,716 $2,378 6.8%
88360 Microscopic genetic analysis of tumor, manual Facility 2022 23 53 $21,472 $1,712 8.0%
88342 Special stained specimen slides to examine tissue, initial procedure Facility 2022 51 55 $15,644 $1,480 9.5%
88307 Pathology examination of tissue using a microscope, moderately high complexity Facility 2022 12 23 $9,841 $1,435 14.6%
88331 Pathology examination of specimen during surgery, first tissue block Facility 2022 18 25 $8,261 $1,198 14.5%
88162 Screening examination of specimen cells, extended study Facility 2022 29 31 $6,903 $915.05 13.3%
88177 Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode Facility 2022 12 13 $1,329 $274.12 20.6%
88141 Pap test Facility 2022 11 12 $1,824 $189.09 10.4%

About Dr. Boulos Beshai, M.D

Dr. Boulos Beshai, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/05/2012. The National Provider Identifier (NPI) number assigned to this provider is 1457621617.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Boulos Beshai, M.D has received a total of $1,958 in payments from pharmaceutical and medical device companies, with $1,907 received in 2024. These payments were reported across 4 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($1,815).

As a Medicare-enrolled provider, Beshai has provided services to 1,796 Medicare beneficiaries, totaling 2,818 services with total Medicare billing of $97,398. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.

Practice Information

Products in Payments

  • JEMPERLI (Biological) $76.07
  • ENHERTU (Biological) $50.56

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Buffalo